CH

Christine Helen Fonseca

Active Director Director DIN 07249218
DIN 07249218 First appointment Jul 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2015
Shareholding value •••• Premium profile

About Christine Helen Fonseca

Data last updated:

Christine Helen Fonseca is a Director at Magdale Pharma Private Limited (since 2015). The company operates in Chemicals. Magdale Pharma Private Limited reported revenue of ₹59.1 Lakh (FY 2024).

DIN 07249218
Primary Designation Director
Industry Chemicals
First Appointment 29 Jul 2015
Oldest Company Age 15 yrs
Largest company Magdale Pharma Private Limited · ₹59.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Magdale Pharma Private Limited U24100MH2011PTC220893
Director29 Jul 20152011₹59.1 Lakh (FY 2024)Active

Board colleagues of Christine Helen Fonseca

NameDINCompanyDesignation
Francis Fonseca01741856Magdale Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Magdale Pharma Private Limited
Premium access

Shareholding and investment profile for Christine Helen Fonseca

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Christine Helen Fonseca

Christine Helen Fonseca currently holds 1 directorship: Magdale Pharma Private Limited (Director, since 29 Jul 2015, revenue ₹59.1 Lakh (FY 2024)).

Christine Helen Fonseca was first appointed on 29 Jul 2015 as Director at Magdale Pharma Private Limited.

The current boards of Christine Helen Fonseca's companies include Francis Fonseca (Magdale Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available